Cancer Care Inc
Cancer Care Inc maintains stable finances with consistent revenue and asset levels, reporting no officer compensation.
EIN: 131825919 · New York, NY · NTEE: G30Z · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $35.0M |
| Total Expenses | $18.6M |
| Program Spending | 80% |
| CEO/Top Officer Pay | $18M |
| Net Assets | $20.2M |
| Transparency Score | 75/100 |
Is Cancer Care Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Cancer Care Inc directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Cancer Care Inc
Cancer Care Inc (EIN: 131825919) is a nonprofit organization based in New York, NY, classified under NTEE code G30Z. The organization reported total revenue of $35.0M and total assets of $23.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cancer Care Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Cancer Care Inc is a large nonprofit that has been operating for 69 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -0.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $18.8M |
| Total Expenses | $18.6M |
| Surplus / Deficit | +$222K |
| Total Assets | $25.9M |
| Total Liabilities | $5.6M |
| Net Assets | $20.2M |
| Operating Margin | 1.2% |
| Debt-to-Asset Ratio | 21.8% |
| Months of Reserves | 16.7 months |
Financial Health Grade: A
In 2023, Cancer Care Inc reported a surplus of $222K with revenue exceeding expenses, holds 16.7 months of operating reserves (strong position), has a debt-to-asset ratio of 21.8% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Cancer Care Inc's revenue has grown at a compound annual growth rate (CAGR) of -0.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -10.2% | +8.1% | +8.3% |
| 2022 | +19.9% | -7.1% | -4.4% |
| 2021 | +3.1% | -0.5% | +5.7% |
| 2020 | -17.1% | +4.8% | +3.6% |
| 2019 | +16.6% | +1.8% | +13.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1957 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Cancer Care Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 80%
- fundraising: 10%
According to IRS 990 filings, Cancer Care Inc allocates its expenses as follows: admin: 10%, programs: 80%, fundraising: 10%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $222K, with revenue exceeding expenses.
- Debt-to-asset ratio: 21.8%.
Executive Compensation Analysis
The consistent reporting of 0% officer compensation across all available filings is unusual for an organization of this size ($18M-$20M annual expenses) and warrants further investigation to understand how leadership is compensated or if it is entirely volunteer-driven.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Cancer Care Inc's IRS 990 filings:
- Consistent 0% officer compensation reported, which is unusual for an organization with annual expenses exceeding $18 million, potentially obscuring true leadership costs.
Strengths
The following positive indicators were identified for Cancer Care Inc:
- Consistent revenue generation, typically between $15M and $20M annually.
- Healthy asset base, consistently above $20M, providing financial stability.
- Liabilities are consistently well-managed and significantly lower than assets, indicating strong financial health.
- Demonstrates resilience by covering expense overages with existing assets in certain periods.
Frequently Asked Questions about Cancer Care Inc
Is Cancer Care Inc a legitimate charity?
Cancer Care Inc (EIN: 131825919) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 75/100. It has 13 years of IRS 990 filings on record. Total revenue: $35.0M. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does Cancer Care Inc spend its money?
Cancer Care Inc directs 80% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to Cancer Care Inc tax-deductible?
Cancer Care Inc is registered as a tax-exempt nonprofit (EIN: 131825919). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Cancer Care Inc CEO make?
Cancer Care Inc's highest-compensated officer earns $18M annually. The organization reported $35.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Cancer Care Inc's spending goes to programs?
Cancer Care Inc directs 80% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Cancer Care Inc compare to similar nonprofits?
With a transparency score of 75/100 (Good), Cancer Care Inc is above average for NTEE category G30Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Cancer Care Inc located?
Cancer Care Inc is headquartered in New York, New York and files with the IRS under EIN 131825919. It is classified under NTEE code G30Z.
How many years of IRS 990 filings does Cancer Care Inc have?
Cancer Care Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $35.0M in total revenue.
How does Cancer Care Inc manage to report 0% officer compensation given its scale?
The filings consistently show 0% officer compensation. This could mean executive roles are entirely volunteer-based, or compensation is categorized differently (e.g., as general salaries), which would require reviewing detailed expense breakdowns in the full 990 forms.
What is the organization's strategy for managing periods where expenses exceed revenue?
In periods like 202106 (expenses $18.46M vs. revenue $17.43M) and 202006 (expenses $18.55M vs. revenue $16.91M), the organization drew from its substantial asset base (e.g., $24.99M in 202106) to cover the deficit, indicating a reliance on reserves during leaner years.
What is the trend in the organization's net assets over the past decade?
Net assets (Assets minus Liabilities) have generally remained strong, fluctuating between approximately $17M and $20M, demonstrating the organization's ability to maintain a healthy financial cushion despite some operational deficits.
Filing History
IRS 990 filing history for Cancer Care Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Cancer Care Inc's revenue has declined by 0.3%, moving from $18.8M to $18.8M. Total assets decreased by 2.2% over the same period, from $26.5M to $25.9M. Total functional expenses rose by 1.4%, from $18.3M to $18.6M. In its most recent filing year (2023), Cancer Care Inc reported a surplus of $222K, with revenue exceeding expenses. The organization holds $5.6M in liabilities against $25.9M in assets (debt-to-asset ratio: 21.8%), resulting in net assets of $20.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $18.8M | $18.6M | $25.9M | $5.6M | — | View 990 |
| 2022 | $20.9M | $17.2M | $23.9M | $4.6M | — | View 990 |
| 2021 | $17.4M | $18.5M | $25.0M | $6.6M | — | View 990 |
| 2020 | $16.9M | $18.6M | $23.7M | $5.9M | — | View 990 |
| 2019 | $20.4M | $17.7M | $22.8M | $3.2M | — | View 990 |
| 2018 | $17.5M | $17.4M | $20.1M | $3.1M | — | View 990 |
| 2017 | $17.0M | $16.6M | $20.2M | $3.1M | — | View 990 |
| 2016 | $15.8M | $17.7M | $19.2M | $3.0M | — | View 990 |
| 2015 | $16.9M | $16.5M | $22.4M | $3.2M | — | View 990 |
| 2014 | $16.1M | $15.3M | $22.9M | $3.2M | — | View 990 |
| 2013 | $13.9M | $15.9M | $21.2M | $3.2M | — | View 990 |
| 2012 | $15.6M | $18.6M | $22.8M | $3.3M | — | View 990 |
| 2011 | $18.8M | $18.3M | $26.5M | $3.3M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $18.8M, expenses of $18.6M, and assets of $25.9M (revenue -10.2% year-over-year).
- 2022: Revenue of $20.9M, expenses of $17.2M, and assets of $23.9M (revenue +19.9% year-over-year).
- 2021: Revenue of $17.4M, expenses of $18.5M, and assets of $25.0M (revenue +3.1% year-over-year).
- 2020: Revenue of $16.9M, expenses of $18.6M, and assets of $23.7M (revenue -17.1% year-over-year).
- 2019: Revenue of $20.4M, expenses of $17.7M, and assets of $22.8M (revenue +16.6% year-over-year).
- 2018: Revenue of $17.5M, expenses of $17.4M, and assets of $20.1M (revenue +3.1% year-over-year).
- 2017: Revenue of $17.0M, expenses of $16.6M, and assets of $20.2M (revenue +7.7% year-over-year).
- 2016: Revenue of $15.8M, expenses of $17.7M, and assets of $19.2M (revenue -6.6% year-over-year).
- 2015: Revenue of $16.9M, expenses of $16.5M, and assets of $22.4M (revenue +4.4% year-over-year).
- 2014: Revenue of $16.1M, expenses of $15.3M, and assets of $22.9M (revenue +16.4% year-over-year).
- 2013: Revenue of $13.9M, expenses of $15.9M, and assets of $21.2M (revenue -10.9% year-over-year).
- 2012: Revenue of $15.6M, expenses of $18.6M, and assets of $22.8M (revenue -17.3% year-over-year).
- 2011: Revenue of $18.8M, expenses of $18.3M, and assets of $26.5M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Cancer Care Inc:
Data Sources and Methodology
This transparency report for Cancer Care Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.